Results 121 to 130 of about 534,042 (160)

<i>RYR1</i> mutations linked to malignant hyperthermia susceptibility are associated with phenotypic changes in human B-lymphocytes. [PDF]

open access: yesFront Immunol
Li H   +10 more
europepmc   +1 more source

CAR T cell therapy beyond cancer: current status, challenges and future prospects. [PDF]

open access: yesSignal Transduct Target Ther
Upadhyay S, Cho S, Upmanyu K, Gabr MT.
europepmc   +1 more source

The immunomodulating effect of palmitoylethanolamide on human myeloid dendritic cells and its possible impact on Alzheimer's disease. [PDF]

open access: yesFront Immunol
Piccolino I   +8 more
europepmc   +1 more source

Dynamic reprogramming of the tumor immune network via multicycle checkpoint degradation for cancer immunotherapy. [PDF]

open access: yesProc Natl Acad Sci U S A
Shi T   +13 more
europepmc   +1 more source

The Levels of Soluble Forms of CD21 and CD83 in Multiple Sclerosis

open access: yesJournal of Neuroimmunology, 2018
Multiple Sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) in which immune system plays a crucial role in progression of the disease. An enormous amount of research has been shown that immune mediators such as cytokines and chemokines are the culprits of MS propagation suggesting that modulation of such molecules may ...
Masoud Etemadifar   +2 more
exaly   +5 more sources

Production and Characterization of Human Soluble CD83 Fused With the Fragment Crystallizable Region of Human IgG1 in Pichia pastoris

open access: yesApplied Microbiology and Biotechnology, 2013
The cell surface protein CD83 belongs to the immunoglobulin superfamily and is highly expressed on mature dendritic cells. The soluble form of CD83, sCD83, is a potential immune suppressor. In a previous study, recombinant soluble CD83 was expressed in Escherichia coli, resulting in a lack of functional glycosylation.
Lin Wan, Younan Chen, Yanrong Lu
exaly   +6 more sources

Expression of Soluble CD83 in Plasma From Early-Stage Rheumatoid Arthritis Patients Is Not Modified by Anti-TNF-α Therapy

open access: yesCytokine, 2017
Rheumatoid arthritis (RA) is an autoimmune disease which may lead to severe disabilities due to structural joint damage and extraarticular manifestations The dendritic cell marker CD83 belongs to the immunoglobulin superfamily and has previously been associated with autoimmune diseases.
Per Höllsberg   +2 more
exaly   +6 more sources

Home - About - Disclaimer - Privacy